Trinity Biotech PLC (TRIB)
1.85
+0.02
(+1.09%)
USD |
NASDAQ |
Apr 25, 12:24
Trinity Biotech Cash from Investing (TTM): 24.51M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 24.51M |
June 30, 2023 | 24.07M |
March 31, 2023 | -5.591M |
December 31, 2022 | -5.977M |
September 30, 2022 | -7.315M |
June 30, 2022 | -7.95M |
March 31, 2022 | -7.509M |
December 31, 2021 | -8.691M |
September 30, 2021 | -6.121M |
June 30, 2021 | -6.853M |
March 31, 2021 | -10.34M |
December 31, 2020 | -10.20M |
September 30, 2020 | -9.903M |
June 30, 2020 | -13.26M |
March 31, 2020 | -11.50M |
December 31, 2019 | -11.85M |
September 30, 2019 | -17.39M |
June 30, 2019 | -23.59M |
March 31, 2019 | -16.44M |
December 31, 2018 | -17.39M |
September 30, 2018 | -16.76M |
June 30, 2018 | -8.236M |
March 31, 2018 | -15.48M |
December 31, 2017 | -16.18M |
September 30, 2017 | -15.45M |
Date | Value |
---|---|
June 30, 2017 | -17.28M |
March 31, 2017 | -21.20M |
December 31, 2016 | -21.88M |
September 30, 2016 | -30.17M |
June 30, 2016 | -27.79M |
March 31, 2016 | -27.90M |
December 31, 2015 | -27.70M |
September 30, 2015 | -27.88M |
June 30, 2015 | -31.08M |
March 31, 2015 | -27.94M |
December 31, 2014 | -27.76M |
September 30, 2014 | -24.00M |
June 30, 2014 | -60.38M |
March 31, 2014 | -61.32M |
December 31, 2013 | -61.19M |
September 30, 2013 | -59.26M |
June 30, 2013 | -20.02M |
March 31, 2013 | -6.526M |
December 31, 2012 | -9.96M |
September 30, 2012 | -6.67M |
June 30, 2012 | -5.545M |
March 31, 2012 | -5.369M |
December 31, 2011 | -0.13M |
September 30, 2011 | -1.533M |
June 30, 2011 | -0.646M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-23.59M
Minimum
Jun 2019
24.51M
Maximum
Sep 2023
-6.414M
Average
-8.320M
Median
Cash from Investing (TTM) Benchmarks
Amarin Corp PLC | -25.52M |
Avadel Pharmaceuticals PLC | -50.09M |
DBV Technologies SA | -0.808M |
Adaptimmune Therapeutics PLC | 176.54M |
Akari Therapeutics PLC | -- |